Article
The systemic activin response to pancreatic cancer: Implications for effective cancer cachexia therapy
2018-06-11
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) is a particularly lethal malignancy with high rates of cachexia. Serum activin correlates with PDAC cachexia and mortality, while activin administration causes cachexia in mice. We studied activin in human tumors and in mice with orthotopic or genetic PDAC. Cachexia severity correlated with activin expression in tumor lines. Activins were expressed in both cancer and tumor s...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4564aae3-8bef-546e-9204-45891a06cf28
- DOI
- 10.1101/343871
